$IAM 4 SEC Filings

Filed On	Filing
19 Oct 2026	Form 4: Vogelstein R Jacob, Director Received 4,196,585 shares by conversion
19 Oct 2026	Form 4: Rachlin Evan Lockwood, Director Received 1,927,252 shares by conversion · Bought 718,750 shares ($11.5M)
19 Oct 2026	Form 4: Catalio Capital Management, Lp, 10% owner and 4 others Received 4,196,585 shares by conversion
19 Oct 2026	Form 4: Secora Michael, CFO & Chief Corp Dev Ofcr Received 61,342 shares by conversion
19 Oct 2026	Form 4: Rastetter William H, Director Received 200,920 shares by conversion
16 Oct 2026	Form 4: Manby Frederick R, Director Received 132,200 shares as a grant or award · Granted 793,200 Employee Stock Option (right to buy)
16 Oct 2026	Form 4: Olson Peter A, Chief Scientific Officer Received 19,500 shares as a grant or award · Granted 116,900 Employee Stock Option (right to buy)
16 Oct 2026	Form 4: Sharp Shalini, Director Granted 20,300 Stock Option (right to buy)
16 Oct 2026	Form 4: Tagliaferri Mary, Director Granted 20,300 10/14/2026
16 Oct 2026	Form 4: Emster Kurt Von, Director Granted 20,300 Stock Option (right to buy)
16 Oct 2026	Form 4: Vogelstein R Jacob, Director Granted 20,300 Stock Option (right to buy)
16 Oct 2026	Form 4: Rachlin Evan Lockwood, Director Granted 20,300 Stock Option (right to buy)
16 Oct 2026	Form 4: Miller Thomas F., Director Received 132,200 shares as a grant or award · Granted 793,200 Employee Stock Option (right to buy)
16 Oct 2026	Form 4: Josephson Neil, Chief Medical Officer Received 31,000 shares as a grant or award · Granted 185,900 Employee Stock Option (right to buy)
16 Oct 2026	Form 4: Secora Michael, CFO & Chief Corp Dev Ofcr Received 28,400 shares as a grant or award · Granted 170,300 Employee Stock Option (right to buy)
16 Oct 2026	Form 4: Rastetter William H, Director Granted 40,600 Stock Option (right to buy)

Comments